Abz-LFK(Dnp)-OH 三氟乙酸盐

• 产品号: A5855
• 分子式: C36H42F3N7O11
• 分子量: 805.7541896
• 纯 度: ≥98% (HPLC)

产品别名

• 标题: Abz-LFK(Dnp)-OH trifluoroacetate salt
• IUPAC标准名: (2S)-2-[(2S)-2-[(2S)-2-[(2-aminophenyl)formamido]-4-methylpentanamido]-3-phenylpropanamido]-6-[(2,4-dinitrophenyl)amino]hexanoic acid; trifluoroacetic acid
• IUPAC传统名: (2S)-2-[(2S)-2-[(2S)-2-[(2-aminophenyl)formamido]-4-methylpentanamido]-3-phenylpropanamido]-6-[(2,4-dinitrophenyl)amino]hexanoic acid; trifluoroacetic acid
• 别名: O-Aminobenzoic acid-Leu-Phe-Lys(DNP)-OH 三氟乙酸盐; O-Aminobenzoic acid-Leu-Phe-Lys(DNP)-OH trifluoroacetate salt

产品登记号

• MDL号: MFCD11045275

产品性质

• Empirical Formula (Hill Notation): C34H41N7O9 · xC2HF3O2 · yH2O
• 纯度: ≥98% (HPLC)
• 外观: white powder
• 溶解度: H2O: >2 mg/mL
• 保存温度: 2-8°C
• 德国WGK号: 3

产品详细信息

详细说明 (English)

Amino Acid Sequence
Abz-Leu-Phe-Lys-DNP
Biochem/physiol Actions
Abz-LFK(Dnp)-OH is an Angiotensin Converting Enzyme (ACE) fluorescent peptide substrate specific for the C domain for real time fluorescent assay (ACE, Peptidyl Dipeptidase, Kininase II, E.C. 3.4.15.1).
Application
Abz-LFK(Dnp)-OH trifluoroacetate (TFA) salt is an Angiotensin Converting Enzyme (ACE) fluorescent peptide substrate that binds specifically to the C domain of ACE. Abz-LFK(Dnp)-OH TFA has been used to study the development of new antibacterial calixarene derivatives, as well as the efficacy and toxicity of the antimicrobial peptide M33 as a possible antimicrobial agent in lung infections and sepsis.

详细说明 (简体中文)

Amino Acid Sequence
Abz-Leu-Phe-Lys-DNP
Biochem/physiol Actions
Abz-LFK(Dnp)-OH is an Angiotensin Converting Enzyme (ACE) fluorescent peptide substrate specific for the C domain for real time fluorescent assay (ACE, Peptidyl Dipeptidase, Kininase II, E.C. 3.4.15.1).
Application
Abz-LFK(Dnp)-OH trifluoroacetate (TFA) salt is an Angiotensin Converting Enzyme (ACE) fluorescent peptide substrate that binds specifically to the C domain of ACE. Abz-LFK(Dnp)-OH TFA has been used to study the development of new antibacterial calixarene derivatives, as well as the efficacy and toxicity of the antimicrobial peptide M33 as a possible antimicrobial agent in lung infections and sepsis.